GSK launches combined Hib/Meningitis C vaccine

GSK has launched Menitorix, a combined conjugate vaccine that provides protection against invasive diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitides serogroup C (MenC).

Menitorix can be used both in the primary vaccination of infants from two months to 12 months, and as a booster in children who have previously completed a primary immunisation series with Menitorix or with other Hib or MenC conjugate vaccines.

The primary immunistion schedule for infants aged two to 12 months comprises three doses, each of 0.5 ml, administered by intramuscular injection at intervals of at least one month apart.
The booster, a single 0.5 ml dose, is usually given from 12 months of age onwards.

Menitorix is supplied as a single dose vial with pre-filled syringe of diluent at a basic NHS price of £39.87.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases